RecruitingNot ApplicableNCT04255615

Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes

The Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF Outcomes


Sponsor

Weill Medical College of Cornell University

Enrollment

4,000 participants

Start Date

Feb 12, 2020

Study Type

INTERVENTIONAL

Conditions

Summary

The use of machine learning techniques using an artificial intelligence tool is proposed to analyze clinical data to predict best possible IVF/ART outcomes. This tool has been utilized to accurately predict embryo quality here at Cornell. Utilizing this tool to assess objective clinical findings and predict outcomes of assisted reproductive techniques is sought, with the ultimate goal of an automated tool to reduce implicit physician bias. Within this goal, using this tool to objectively and accurately assess baseline ovarian reserve at the start of an ART cycle is proposed, using 3D sonography to image the ovary and artificial intelligence tool to objectively identify baseline antral follicle counts.


Eligibility

Min Age: 18 YearsMax Age: 89 Years

Inclusion Criteria3

  • All patients undergoing ovarian stimulation (including OI and IVF cycles)
  • Treatment for fresh embryo transfer and cryopreservation of oocytes or embryos upfront
  • Healthy male partners of the female subjects who agree to be part of the study.

Exclusion Criteria1

  • None

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERAI to analyze 3 D ultrasound

AI to assess 3 D ultrasound to assess antral follicle count


Locations(1)

Weill Cornell Medicine

New York, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04255615


Related Trials